Eton Pharmaceuticals (ETON) Finished Goods (2024 - 2026)
Eton Pharmaceuticals (ETON) posted Finished Goods of $6.6 million for Q4 2025, down 7.84% sequentially from $7.2 million in Q4 2024, and down 7.84% YoY from $7.2 million in Q4 2024.
Eton Pharmaceuticals (ETON) Finished Goods (2024 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Finished Goods for 2 years, with the latest figure at $6.6 million in Q4 2025.
- Quarterly Finished Goods fell 7.84% year-over-year to $6.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.6 million (down 7.84% YoY) and the FY2025 annual result came in at $6.6 million, down 7.84% from the prior year.
- Finished Goods declined to $6.6 million in Q4 2025 per ETON's latest filing, from $7.2 million in the prior quarter.
- Over five years, Finished Goods peaked at $7.2 million in Q4 2024 and troughed at $6.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.85 Mn |
| Dec 31, 2025 | 6.63 Mn |
| Dec 31, 2024 | 7.19 Mn |